Frost & Sullivan Honors Leaders in Pharmaceuticals & Life Sciences

18-Nov-2004

Frost & Sullivan honored industry leaders for outstanding performance in healthcare markets at last week's Excellence in Pharmaceuticals & Life Sciences Awards Banquet held in Naples, Florida.

The banquet recognized companies that are predicted to encourage significant growth in their industries, have identified emerging trends before they became the standard in the marketplace, and have created advanced technologies that will catalyze industries in the near future.

A CEO Roundtable Discussion preceded the banquet earlier that day, moderated by Marah Walsh, Publisher/Creative Director of PharmaVOICE. During the CEO Roundtable Discussion, panelists answered a variety of questions focusing on competitive intelligence, advanced marketing research, and the challenges of succeeding in a demanding economy. An open networking session followed, allowing the recipient companies to develop and strengthen business relationships with each other.

Awarded companies included:

-- ABIOMED Inc. - 2004 Technology Leadership Award for the Circulatory Assist Devices Market

-- Access Genetics - 2004 Technology Innovation Award for the Medical Diagnostics Market

-- Alizyme - 2004 Frost & Sullivan Technology Innovation Award for the Irritable Bowel Syndrome Therapeutics Markets

-- Amisys Synertech Inc. - 2004 Business Development Strategy Leadership Award for Health Plan Administration Solutions

-- Cambridge Heart - 2004 Technology Innovation Award for the Total Electrocardiography Market

-- Cedara Software Corp. - 2004 Medical Imaging Fastest Growing Company Award for the Medical Imaging Market

-- Health Hero Network - 2004 Product Innovation Excellence Award for the Remote Patient Monitoring Devices Markets

-- Hologic Inc. - 2004 Frost & Sullivan Technology Leadership Award for the Women's Health Diagnostics for Cancer Market

-- King Pharmaceuticals - 2004 Frost & Sullivan Product Value Enhancement Award for the Insomnia Therapies Markets

-- Leiner Health Products - 2004 Frost & Sullivan Product Launch Strategy Award for the Anti-Allergic Therapies Market

-- Ligand Pharmaceuticals - 2004 Business Development Strategy Leadership Award for the Pharmaceutical Market

-- Lodox Systems LLC - 2004 Excellence in Technology Award for the Medical Imaging Market

-- Mallinckrodt Pharmaceutical Group - 2004 Specialty Product Award for the Insomnia Therapies Market

-- Otsuka America Pharmaceutical Inc. - Product Innovation of the Year Award for the Antipsychotic Medications Market

-- Picis - 2004 Product Line Strategy Leadership Award for the Specialty Care Solutions Market

-- Puritan Bennett - 2004 Product Quality Leadership of the Year Award for Oxygen Therapy Market

-- Prometic Life Sciences - 2004 Technology Leadership of the Year Award for the Bioseparation Market

-- Proxim Corporation - 2004 Product Line Strategy Leadership Award for Emerging Wireless Markets for Patient Care

-- R2 Technology Inc. - 2004 Product of the Year Award for Medical Imaging

-- Roche Diagnostics - 2004 Company of the Year Award for Clinical Diagnostics

-- Synthon Pharmaceuticals - 2004 Customer Value Innovation Award for Neurology

-- Vital Images Inc. - CEO of the Year Award for Medical Imaging

-- Viterion - 2004 Product of the Year Award for Patient Monitoring

-- YM Biosciences - 2004 Frost & Sullivan Entrepreneurial Company Award for Breast Cancer Therapies Markets

-- Zebra Technologies - 2004 Product Leadership of the Year Award for Medical Informatics

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures